Journal
NATURE CHEMISTRY
Volume 9, Issue 7, Pages 715-722Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/NCHEM.2749
Keywords
-
Categories
Funding
- University of California Cancer Research Coordinating Committee
- National Science Foundation [DMR-1308363]
- Kurata Memorial Hitachi Science and Technology Foundation
- Uehara Memorial Foundation
- [25-426]
- [23111716]
- [25107726]
- [23685027]
- Grants-in-Aid for Scientific Research [17K14519, 15H03818, 16K14007] Funding Source: KAKEN
Ask authors/readers for more resources
Protein affinity reagents are widely used in basic research, diagnostics and separations and for clinical applications, the most common of which are antibodies. However, they often suffer from high cost, and difficulties in their development, production and storage. Here we show that a synthetic polymer nanoparticle (NP) can be engineered to have many of the functions of a protein affinity reagent. Polymer NPs with nM affinity to a key vascular endothelial growth factor (VEGF(165)) inhibit binding of the signalling protein to its receptor VEGFR-2, preventing receptor phosphorylation and downstream VEGF(165)-dependent endothelial cell migration and invasion into the extracellular matrix. In addition, the NPs inhibit VEGF-mediated new blood vessel formation in Matrigel plugs in vivo. Importantly, the non-toxic NPs were not found to exhibit off-target activity. These results support the assertion that synthetic polymers offer a new paradigm in the search for abiotic protein affinity reagents by providing many of the functions of their protein counterparts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available